Similar articles for PMID: 17088085

Year	Number of Results
1979	1
1997	1
1998	1
2003	1
2004	1
2005	2
2006	8
2007	12
2008	8
2009	15
2010	2
2011	6
2012	2
2013	4
2014	5
2015	2
2016	3
2017	3
2018	3
2019	4
2020	6
2021	5
2022	5
2024	0

1

Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.

Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T, Kaneko H, Kondo N, Tsuge I, Yachie A, Sakiyama Y, Iwata T, Bessho F, Ohishi T, Joh K, Imai K, Kogawa K, Shinohara M, Fujieda M, Wakiguchi H, Pasic S, Abinun M, Ochs HD, Renner ED, Jansson A, Belohradsky BH, Metin A, Shimizu N, Mizutani S, Miyawaki T, Nonoyama S, Karasuyama H. Minegishi Y, et al. Immunity. 2006 Nov;25(5):745-55. doi: 10.1016/j.immuni.2006.09.009. Immunity. 2006. PMID: 17088085 Free article.

2

Hyperimmunoglobulin E syndrome and tyrosine kinase 2 deficiency.

Minegishi Y, Karasuyama H. Minegishi Y, et al. Curr Opin Allergy Clin Immunol. 2007 Dec;7(6):506-9. doi: 10.1097/ACI.0b013e3282f1baea. Curr Opin Allergy Clin Immunol. 2007. PMID: 17989526 Review.

3

Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency.

Minegishi Y, Karasuyama H. Minegishi Y, et al. Int Immunol. 2009 Feb;21(2):105-12. doi: 10.1093/intimm/dxn134. Epub 2008 Dec 15. Int Immunol. 2009. PMID: 19088064 Review.

4

Human tyk2 kinase deficiency: another primary immunodeficiency syndrome.

Watford WT, O'Shea JJ. Watford WT, et al. Immunity. 2006 Nov;25(5):695-7. doi: 10.1016/j.immuni.2006.10.007. Immunity. 2006. PMID: 17098200 Free article. Review.

5

Hyper-IgE syndrome.

Minegishi Y. Minegishi Y. Curr Opin Immunol. 2009 Oct;21(5):487-92. doi: 10.1016/j.coi.2009.07.013. Epub 2009 Aug 28. Curr Opin Immunol. 2009. PMID: 19717292 Review.

6

Severely impaired IL-12/IL-18/IFNgamma axis in patients with hyper IgE syndrome.

Netea MG, Kullberg BJ, van der Meer JW. Netea MG, et al. Eur J Clin Invest. 2005 Nov;35(11):718-21. doi: 10.1111/j.1365-2362.2005.01564.x. Eur J Clin Invest. 2005. PMID: 16269022

7

Tyrosine kinase 2 is not limiting human antiviral type III interferon responses.

Fuchs S, Kaiser-Labusch P, Bank J, Ammann S, Kolb-Kokocinski A, Edelbusch C, Omran H, Ehl S. Fuchs S, et al. Eur J Immunol. 2016 Nov;46(11):2639-2649. doi: 10.1002/eji.201646519. Epub 2016 Oct 5. Eur J Immunol. 2016. PMID: 27615517 Free article.

8

Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia.

Nemoto M, Hattori H, Maeda N, Akita N, Muramatsu H, Moritani S, Kawasaki T, Maejima M, Ode H, Hachiya A, Sugiura W, Yokomaku Y, Horibe K, Iwatani Y. Nemoto M, et al. Sci Rep. 2018 May 3;8(1):6956. doi: 10.1038/s41598-018-25260-8. Sci Rep. 2018. PMID: 29725107 Free PMC article.

9

Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.

Couturier N, Bucciarelli F, Nurtdinov RN, Debouverie M, Lebrun-Frenay C, Defer G, Moreau T, Confavreux C, Vukusic S, Cournu-Rebeix I, Goertsches RH, Zettl UK, Comabella M, Montalban X, Rieckmann P, Weber F, Müller-Myhsok B, Edan G, Fontaine B, Mars LT, Saoudi A, Oksenberg JR, Clanet M, Liblau RS, Brassat D. Couturier N, et al. Brain. 2011 Mar;134(Pt 3):693-703. doi: 10.1093/brain/awr010. Brain. 2011. PMID: 21354972

10

Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.

Lee N, Wong CK, Chan PK, Lun SW, Lui G, Wong B, Hui DS, Lam CW, Cockram CS, Choi KW, Yeung AC, Tang JW, Sung JJ. Lee N, et al. Clin Infect Dis. 2007 Sep 15;45(6):723-31. doi: 10.1086/520981. Epub 2007 Aug 8. Clin Infect Dis. 2007. PMID: 17712756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

90 results

Results by year